$NBIO on alert! CEO Sean Carrick remarked: "We are pleased to be featured in this independent prospective of Nascent's investment potential. This report underscores our internal conviction that the Company's common stock is presently undervalued." https://finance.yahoo.com/news/nascent-biotech-receives-analyst-opinion-130000256.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance